Kyri K. Van Hoose

Insider Reports History

Location
C/O Turning Point Therapeutics, Inc., 10628 Science Center Drive, Suite 200, San Diego, CA
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyri K. Van Hoose:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dermata Therapeutics, Inc. SVP, CFO Common Stock 78.7K Jan 21, 2025 Direct
Dermata Therapeutics, Inc. SVP, CFO Warrant (Right to Buy) 78.7K Jan 21, 2025 Direct
Dermata Therapeutics, Inc. SVP, CFO Stock Option (right to buy) 20K Jan 13, 2025 Direct

Insider Reports Filed by Kyri K. Van Hoose

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DRMA Dermata Therapeutics, Inc. Jan 21, 2025 2 $0 4 Jan 23, 2025 SVP, CFO
DRMA Dermata Therapeutics, Inc. Jan 13, 2025 1 $0 4 Jan 14, 2025 SVP, CFO
DRMA Dermata Therapeutics, Inc. Jan 4, 2024 1 $0 4 Jan 5, 2024 SVP, CFO
DRMA Dermata Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 SVP, CFO
DRMA Dermata Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 SVP, Chief Financial Officer
DRMA Dermata Therapeutics, Inc. Sep 1, 2021 1 $0 4 Sep 1, 2021 Chief Financial Officer
DRMA Dermata Therapeutics, Inc. Sep 1, 2021 0 $0 3 Sep 1, 2021 Chief Financial Officer
TPTX Turning Point Therapeutics, Inc. May 14, 2021 0 $0 3 May 14, 2021 Principal Accounting Officer